Point Roberts, WA and Vancouver, BC - August 21, 2020 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today's edition of The AI Eye - watching stock news, deal tracker and advancements in artificial intelligence.
Listen to today's podcast:AI Eye Episode 416: AstraZeneca (NYSE: $AZN) Collaborating with Renalytix AI (NasdaqGM: $RNLX) for Precision Medicine Strategies and Nuance (NasdaqGS: $NUAN) Advances Virtual Assistant Tech for Hey Epic! Voice Assistant
Today's Column - The AI Eye - Watching stock news, deal tracker and advancements in artificial intelligenceStocks discussed: (NYSE:AZN) (NasdaqGM:RNLX) (NasdaqGS:NUAN)
Pharmaceutical giant AstraZeneca (NYSE:AZN) and artificial intelligence diagnostics firm Renalytix AI (NasdaqGM:RNLX) are collaborating to develop and launch precision medicine strategies for cardiovascular, renal and metabolic diseases. According to the press release, "the first stage in the collaboration will use KidneyIntelX, an artificial intelligence-enabled in vitro diagnostic platform, to examine further improving outcomes for patients with chronic kidney disease (CKD) and its complications, in coordination with the Mount Sinai Health System." Barbara Murphy, Dean for Clinical Integration and Population Health Management at the Icahn School of Medicine at Mount Sinai, and board member of RenalytixAI, commented:
"We believe this collaboration will define how we can leverage KidneyIntelX to improve the care and outcomes for patients affected by chronic diseases, such as kidney disease, diabetes, and cardiovascular disease. By using a more personalized approach, our initial goal is to help realize improved outcomes for more than 240,000 patients with chronic kidney disease within the Mount Sinai Health System."
Nuance Communications, Inc. (NasdaqGS:NUAN) has announced "the advancement of Nuance's virtual assistant technology for customers using the Epic electronic health record (EHR)," integrating with Hey Epic! voice assistant. Peter Durlach, senior vice president, strategy and new business development, Nuance, said:
"We have long focused our conversational AI innovation on keeping a healthy balance for physicians and nurses between necessary administrative tasks and their primary clinical work. Our virtual assistant and ambient intelligence solutions are not just addressing that balance - they are helping to power the digital transformation of healthcare."Global Deep Learning Market to Reach $37.98 Billion by 2027
A report from Data Bridge Market Research finds that the global Deep Learning market is projected to reach $37.98 billion by 2027 with a compound annual growth rate (CAGR) of 34 percent in the forecast period 2020-2027. An excerpt from the report description reads:
Some of the factors driving the market growth are: advancing computing potential, including diminishing device price, progressing enactment of cloud-based technology, penetration of deep learning practice in big data [systems], and increasing artificial intelligence acceptance in client-centric assistance.
During the [forecast period] some of the factor[s] [that] may hinder the market growth [include]: [the] developing complexity in tools due to complicated algorithms applied in technology, the need for technological experts and the deficiency of measures and customs. To overcome these hindrance[s], [the] existence of insufficient structured data is expected to boost the market for deep learning solutions, and [the] heightening expenditure in travel, hospitality businesses, and [the] healthcare industry will act as opportunity for the market growth.
Sam Mowers, Investorideas.com
About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.
The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.
Visit the Podcast page at Investorideas.com:
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
The AI Eye - Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
800 665 0411Buy a technology guest post on Investorideas.com